In 2021 we presented an interim analysis of reported deaths associated with Covid-19 using data from the Vaccine Adverse Events Reporting System (VAERS). This work applies the same analytical approach used on the original 250 reports from the December 2020 to March 2021 VAERS dataset, to a larger collection containing 1012 reports from the December 2021 to March 2022 VAERS dataset. Crucial differences between both data sets are that in the original data set the vaccination regime was targeted primarily to the elderly and front-line healthcare workers, while in this more recent dataset the vaccines were broadly available to most of the community. Our analysis indicates that: (i) as the vaccines were rolled out to each younger age group, VAERS reports for that age group also grew; (ii) that the identified disparity between male and female VAERS death reports in the 2021 cohort became less pronounced in the 2022 cohort; (iii) that cardiac and diabetic comorbidities continue to be significantly correlated with a VAERS death report; and (iv) that almost half of all death reports in the 2022 cohort include evidence of the individual having been diagnosed with a breakthrough Covid-19 infection. While there are concerns regarding the accuracy and quality of the data recorded on the VAERS system, there is a precedent for using this database. Even taking these concerns into account, the present analysis is consistent with many of the insights and key determinants of mortality identified in the previous analysis. Compared to adverse events associated with all other vaccines in the VAERS database, there is a significant increase in deaths associated with covid-19 vaccines.
No comments:
Post a Comment